We are live on
!
Find out more
Oric Pharmaceuticals
ORIC
ORIC
70 hedge funds and large institutions have $189M invested in Oric Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 18 increasing their positions, 17 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
50% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 12
39% more call options, than puts
Call options by funds: $163K | Put options by funds: $117K
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
9% more funds holding
Funds holding: 64 → 70 (+6)
6% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 17
2% less capital invested
Capital invested by funds: $192M → $189M (-$3.61M)
8.66% less ownership
Funds ownership: 81.94% → 73.28% (-8.7%)
Holders
70
Holders Change
+6
Holders Change %
+9.38%
% of All Funds
1.12%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.1%
New
18
Increased
18
Reduced
17
Closed
12
Calls
$163K
Puts
$117K
Net Calls
+$46K
Net Calls Change
-$804K
Top Buyers
| 1 |
Millennium Management
New York
|
+$2M |
| 2 |
PM
Prosight Management
Dallas,
Texas
|
+$1.91M |
| 3 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$1.9M |
| 4 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$1.04M |
| 5 |
Jane Street
New York
|
+$905K |
Top Sellers
| 1 |
AG
Artal Group
Luxembourg
|
-$2.36M |
| 2 |
OMC
Oasis Management Company
Grand Cayman,
Cayman Islands
|
-$1.6M |
| 3 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$1.4M |
| 4 |
O
OrbiMed
New York
|
-$1.22M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$636K |
